PulmoBioMed – a Northumbria University spin-out which has developed a new lung test that could lead to earlier diagnosis of asthma and other conditions – has raised £1.4m to help commercialize its technology.
Modifying the gut microbiota can ameliorate hypertensive kidney damage and inflammation
New research in rodents indicates that altering gut microbes may affect the development of organ damage associated with hypertension.
November 3, 2023